PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
Holders of 5% or more of PMVP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of PMV Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. | 13G | 9.90%7.58M shares | New | Sep 15, 20261 filing | Sep 15, 2026 | SEC |
| BML Investment Partners, L.P. | 13G/A | 9.90%5.29M shares | +3.20 ppfrom 6.70% | Feb 14, 20253 filings | Feb 9, 2026 | SEC |
| Tang Capital Management LLC | 13G | 8.90%4.72M shares | New | Sep 23, 20251 filing | Sep 23, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
36 Schedule 13D and 13G filings on PMV Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 20266:43 PM ET | Samsara BioCapital, L.P.and 4 others | 13G | 9.90%7.58M shares | New | Sep 2, 2026 | SEC |
| Jul 28, 20264:48 PM ET | Sio Capital Management, LLC | 13G/A | 4.94%2.63M shares | −0.83 ppfrom 5.77%Below 5% | Jun 30, 2026 | SEC |
| Jul 10, 202611:40 AM ET | ArrowMark Colorado Holdings LLC | 13G/A | 3.67%1.96M shares | −2.14 ppfrom 5.81%Below 5% | Jun 30, 2026 | SEC |
| May 15, 20264:05 PM ET | Euclidean Capital LLCand 6 others | 13G/A | 4.90%2.63M shares | –Below 5% | Mar 31, 2026 | SEC |
| May 4, 20264:14 PM ET | Sio Capital Management, LLC | 13G/A | 5.77%3.08M shares | +0.79 ppfrom 4.98% | Mar 31, 2026 | SEC |
| Mar 4, 20269:12 PM ET | OrbiMed Advisors LLCand 1 other | 13D/A | 0.00%0 shares | −9.40 ppfrom 9.40%Below 5% | Mar 2, 2026 | SEC |
| Feb 17, 20264:36 PM ET | ArrowMark Colorado Holdings LLC | 13G/A | 5.81%3.09M shares | – | Dec 31, 2025 | SEC |
| Feb 9, 20262:19 PM ET | BML Investment Partners, L.P. | 13G/A | 9.90%5.29M shares | +3.20 ppfrom 6.70% | Dec 31, 2025 | SEC |
| Nov 12, 20258:00 AM ET | Sio Capital Management, LLC | 13G/A | 4.98%2.64M shares | −2.21 ppfrom 7.19%Below 5% | Sep 30, 2025 | SEC |
| Oct 27, 20255:12 PM ET | OrbiMed Advisors LLCand 1 other | 13D/A | 9.40%4.98M shares | – | Oct 23, 2025 | SEC |
| Sep 23, 20258:34 PM ET | Tang Capital Management LLCand 5 others | 13G | 8.90%4.72M shares | New | Sep 16, 2025 | SEC |
| Aug 14, 20254:02 PM ET | PFM Health Sciences, LPand 3 others | 13G/A | 0.00%0 shares | −6.40 ppfrom 6.40%Below 5% | Jun 30, 2025 | SEC |
| Aug 13, 20252:00 PM ET | Sio Capital Management, LLC | 13G/A | 7.19%3.74M shares | 0.00 ppfrom 7.19% | Jun 30, 2025 | SEC |
| May 15, 20254:08 PM ET | PFM Health Sciences, LPand 3 others | 13G/A | 6.40%3.30M shares | +1.40 ppfrom 5.00% | Mar 31, 2025 | SEC |
| Apr 8, 20253:14 PM ET | Sio Capital Management, LLC | 13G | 7.19%3.74M shares | +0.29 ppfrom 6.90% | Mar 31, 2025 | SEC |
| Feb 21, 20254:02 PM ET | PFM Health Sciences, LPand 3 others | 13G | 5.00%2.60M shares | New | Feb 13, 2025 | SEC |
| Feb 14, 202510:15 AM ET | BML Investment Partners, L.P. | 13G/A | 6.70%3.47M shares | +0.40 ppfrom 6.30% | Dec 31, 2024 | SEC |
| Feb 14, 202510:06 AM ET | BML Investment Partners, L.P. | 13G/A | 6.30%3.27M shares | – | Dec 31, 2024 | SEC |
| Feb 10, 202512:58 PM ET | Sio Capital Management, LLC | 13G | 6.90%3.57M shares | New | Dec 31, 2024 | SEC |
| Feb 14, 2022 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Euclidean Capital LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Interwest Partners X LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Nextech V Oncology S.C.S., SICAV-SIF | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | RTW Investments, LP | 13GOld format | – | New | – | SEC |
| Feb 11, 2022 | Avoro Capital Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Jan 26, 2022 | JPMorgan Chase & Co | 13GOld format | – | New | – | SEC |
| Jan 19, 2022 | Cowen Financial Products LLC | 13GOld format | – | New | – | SEC |
| Oct 18, 2021 | Euclidean Capital LLC | 13G/AOld format | – | – | – | SEC |
| May 7, 2021 | Euclidean Capital LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Viking Global Investors LPSuperinvestorViking Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Nextech V Oncology S.C.S., SICAV-SIF | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Euclidean Capital LLC | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Interwest Partners X LP | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Avoro Capital Advisors LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell PMV Pharmaceuticals, Inc. shares.
No Form 144 notices for PMV Pharmaceuticals, Inc. are on file.